Filing Flows

Filing Flows › Comparisons › ZVRA vs HRTX

Zevra Therapeutics vs Heron Therapeutics: ZVRA and HRTX compared

Zevra Therapeutics is the larger company: $37.8M of revenue in its latest quarter (Q3 2026) against $37.7M for Heron Therapeutics (Q2 2026). Zevra Therapeutics is growing faster (+45% against +1% a year earlier). Zevra Therapeutics is more profitable, with an operating margin of 30.7% against -5.4%.

Zevra Therapeutics vs Heron Therapeutics, latest quarterZevra Therapeutics vs Heron Therapeutics, latest quarterZevra Therapeutics (ZVRA)Heron Therapeutics (HRTX)Revenue$37.8M$37.7MRevenue growth, Y/Y+45%+1%Operating margin30.7%-5.4%Net margin50.9%-14.6%

Where the money goes: ZVRA and HRTX

Zevra Therapeutics (ZVRA) · Q3 2026

Zevra Therapeutics, Q3 2026: revenue $37.8M (+45% year over year), operating margin 30.7%, net earnings $19.2M, operating cash flow $10.0M. The chart follows the revenue to costs, profit and cash.

Heron Therapeutics (HRTX) · Q2 2026

Heron Therapeutics, Q2 2026: revenue $37.7M (+1% year over year), operating margin -5.4%, net loss $5.5M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.

Heron Therapeutics revenue by segment, Q2 2026Heron Therapeutics revenue by segment, Q2 2026CINVANTI$21.8MZYNRELEF$11.1MAponvie$4.3MSUSTOL$540K
Zevra Therapeutics (ZVRA)Heron Therapeutics (HRTX)
Latest quarterQ3 2026Q2 2026
Revenue$37.8M$37.7M
Revenue growth, Y/Y+45%+1%
Operating margin30.7%-5.4%
Net earnings$19.2M−$5.5M
Net margin50.9%-14.6%
Operating cash flow$10.0M−$2.2M
Free cash flow$9.8M—
Market value$636M—
P/E8.5×—
Analysts’ mean target$25.25—

Where the revenue comes from

Heron Therapeutics

Questions

Which is bigger, Zevra Therapeutics or Heron Therapeutics?

Zevra Therapeutics is the larger company: $37.8M of revenue in its latest quarter (Q3 2026) against $37.7M for Heron Therapeutics (Q2 2026).

Is Zevra Therapeutics or Heron Therapeutics growing faster?

Zevra Therapeutics is growing faster (+45% against +1% a year earlier).

Which is more profitable, Zevra Therapeutics or Heron Therapeutics?

Zevra Therapeutics is more profitable, with an operating margin of 30.7% against -5.4%.

More: Zevra Therapeutics earnings · how Zevra Therapeutics makes money · Heron Therapeutics earnings · how Heron Therapeutics makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Aug 10, 2026). Fiscal quarters can end on different dates. Not investment advice.